APPLICATION
ANDA213988
TYPE
ANDA
ORIGINAL APPROVAL
2024-05-08
LATEST ACTION
2026-06-03
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
VASOPRESSIN IN DEXTROSE 5%Prescription
VASOPRESSIN 40UNITS/100ML (0.4UNITS/ML) · SOLUTION · INTRAVENOUS
VASOPRESSINPrescription
VASOPRESSIN 20UNITS/ML (20UNITS/ML) · SOLUTION · INTRAVENOUS
Approval history
2026-06-03Manufacturing (CMC) · Supplement 2 · unknownAP
2026-06-03Manufacturing (CMC) · Supplement 3 · unknownAP
2024-05-08UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.